Literature DB >> 16875787

Confirmatory factor analyses and reliability of the modified cigarette evaluation questionnaire.

Joseph C Cappelleri1, Andrew G Bushmakin, Christine L Baker, Elizabeth Merikle, Abayomi O Olufade, David G Gilbert.   

Abstract

We examined the validity and reliability of the modified Cigarette Evaluation Questionnaire (mCEQ) that assesses the degree to which subjects experience the reinforcing effects of smoking. Data came from three phase II clinical trials (n=626, n=627, n=312) on varenicline for smoking cessation. Comparative fit indexes and non-normed fit indexes from a confirmatory factor analysis exceeded 0.90. Cronbach's alpha for internal consistency reliability exceeded 0.70 for the Smoking Satisfaction domain and the Psychological Reward domain but was less than 0.70 for the Aversion domain; test-retest reliability generally exceeded 0.70 on the three multi-item domains and two single items. The validity and, in general, the reliability of the postulated multidimensional framework of the mCEQ are confirmed and supported by the analyses of three independent studies, with multi-item domains on Smoking Satisfaction (satisfying, taste good, enjoy smoking), Psychological Reward (calm down, more awake, less irritable, help concentrate, reduce hunger), and Aversion (dizziness, nauseous), as well as the single-item assessment on Enjoyment of Respiratory Tract Sensations and on Craving Reduction.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16875787     DOI: 10.1016/j.addbeh.2006.06.028

Source DB:  PubMed          Journal:  Addict Behav        ISSN: 0306-4603            Impact factor:   3.913


  113 in total

1.  A pilot study to assess smokeless tobacco use reduction with varenicline.

Authors:  Jon O Ebbert; Ivana T Croghan; Frederick North; Darrell R Schroeder
Journal:  Nicotine Tob Res       Date:  2010-08-19       Impact factor: 4.244

2.  Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Stephanie S O'Malley
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

3.  Response to reduced nicotine content cigarettes among smokers differing in tobacco dependence severity.

Authors:  Stephen T Higgins; Cecilia L Bergeria; Danielle R Davis; Joanna M Streck; Andrea C Villanti; John R Hughes; Stacey C Sigmon; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Jeff S Priest; Joan M Skelly; Derek D Reed; Janice Y Bunn; Morgan A Tromblee; Christopher A Arger; Mollie E Miller
Journal:  Prev Med       Date:  2018-04-04       Impact factor: 4.018

4.  Reinforcing effects of nicotine and non-nicotine components of cigarette smoke.

Authors:  Jed E Rose; Al Salley; Frederique M Behm; James E Bates; Eric C Westman
Journal:  Psychopharmacology (Berl)       Date:  2010-04-01       Impact factor: 4.530

5.  Effectiveness of switching to very low nicotine content cigarettes plus nicotine patch versus reducing daily cigarette consumption plus nicotine patch to decrease dependence: an exploratory randomized trial.

Authors:  Elias M Klemperer; John R Hughes; Peter W Callas; Joy A Benner; Nicholas E Morley
Journal:  Addiction       Date:  2019-06-30       Impact factor: 6.526

6.  An exploratory examination of the mechanisms through which pre-quit patch use aids smoking cessation.

Authors:  Natalie Schüz; Stuart G Ferguson
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

7.  Perceived medication assignment during a placebo-controlled laboratory study of varenicline: temporal associations of treatment expectancies with smoking-related outcomes.

Authors:  John B Correa; Bryan W Heckman; Nicole S Marquinez; David J Drobes; Marina Unrod; Richard G Roetzheim; Thomas H Brandon
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

8.  Intermittent and daily smokers' subjective responses to smoking.

Authors:  Saul Shiffman; Lauren Terhorst
Journal:  Psychopharmacology (Berl)       Date:  2017-07-18       Impact factor: 4.530

9.  Resisting the urge to smoke and craving during a smoking quit attempt on varenicline: results from a pilot fMRI study.

Authors:  Karen J Hartwell; Todd Lematty; Aimee L McRae-Clark; Kevin M Gray; Mark S George; Kathleen T Brady
Journal:  Am J Drug Alcohol Abuse       Date:  2013-03       Impact factor: 3.829

10.  Effects of varenicline and bupropion sustained-release use plus intensive smoking cessation counseling on prolonged abstinence from smoking and on depression, negative affect, and other symptoms of nicotine withdrawal.

Authors:  Paul M Cinciripini; Jason D Robinson; Maher Karam-Hage; Jennifer A Minnix; Cho Lam; Francesco Versace; Victoria L Brown; Jeffrey M Engelmann; David W Wetter
Journal:  JAMA Psychiatry       Date:  2013-05       Impact factor: 21.596

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.